Related Experiment Video
Updated: Sep 16, 2025

The Sleep Nullifying Apparatus: A Highly Efficient Method of Sleep Depriving Drosophila
Published on: December 14, 2020
Who Is Supplied With In-Bed Sleepers (Pēpi-Pod and Wahakura) for Reducing SUDI in New Zealand?
Edwin A Mitchell1, Stephanie Cowan2, Jessica Wilson1
1Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.
Aims:
Smoking during pregnancy when combined with bedsharing is a major risk factor for Sudden Unexpected Death in Infancy (SUDI). In-bed sleepers like Pēpi-Pod and wahakura provide a safe space for infants within adult beds. But the distribution and reach of these devices to high-risk infants remain unclear. Therefore, this study aimed to assess who receives in-bed sleepers and determine if they are reaching infants at the highest risk of SUDI.
Methods:
We conducted a retrospective cross-sectional study combining sales data analysis of Pēpi-Pod in-bed sleepers with data from the National Maternity Collection, Ministry of Health and Change for our Children from 2019 to 2021. We compared characteristics of infants receiving in-bed sleepers with all New Zealand births.
Results:
An estimated 15.9% of all infants born in New Zealand during 2019-2021 received in-bed sleepers, with significant regional variations. Only 37.5% of infants that were exposed to smoking during pregnancy received an in-bed sleeper. Of in-bed sleepers supplied, 72.9% were supplied to infants not exposed to smoking in pregnancy. In-bed sleeper reporting was poor, with only 36.4% of those supplied being reported.
Conclusion:
The distribution of in-bed sleepers is not optimally targeted, consistently failing to reach high-risk infants, particularly those exposed to smoking in pregnancy. Therefore, improved strategies for distribution and reporting are necessary to enhance the effectiveness of this SUDI prevention measure.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Management of Insomnia

